A Time-to-effect Based Dosing Strategy in Cryoballoon Ablation of Patients With Paroxysmal Atrial Fibrillation

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 140 participants.

Also called NCT02789358

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 140 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02789358
Other papers using this trial's data
  • Time-to-Effect-Based Dosing Strategy for Cryoballoon Ablation in Patients With Paroxysmal Atrial Fibrillation: Results of the plusONE Multicenter Randomized Controlled Noninferiority Trial Circulation. Arrhythmia and electrophysiology, 2017-12 DOI, PubMed 29247029

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Spain (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02789358. Randomized; single masking; primary purpose treatment. Start 2015-12 (registry gives no type); primary completion 2016-06 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Time-to-effect Based Dosing Strategy in Cryoballoon Ablation of Patients With Paroxysmal Atrial Fibrillation
Acronym
plusONE
Intervention (Other)
Conventional cryotherapy dosage
Intervention (Other)
Experimental cryotherapy dosage
Intervention (Device)
Arctic Front Advance ST Cryoenergy Balloon Catheter
Intervention (Drug)
Adenosine triphosphate
Intervention (Device)
nECG platform Nuubo®
Lead sponsor
Fundación para la Investigación del Hospital Clínico de Valencia (class: other)

Record details

Record id
cardio:ct-nct02789358
Content hash
9c5bb22e468e8a4970ea5370ba2064be15715db97975c50cc452766bc759c667